Literature DB >> 22889564

Clinical outcome of supracricoid laryngectomy with cricohyoidoepiglottopexy: radiation failure versus previously untreated patients.

Meijin Nakayama1, Makito Okamoto, Kazushige Hayakawa, Hiromichi Ishiyama, Shouko Kotani, Shunsuke Miyamoto, Yutomo Seino, Tabito Okamoto, Itaru Soda, Akane Sekiguchi.   

Abstract

OBJECTIVE: A history of radiation therapy is known to be a major risk factor promoting post-surgical complications. By comparing the clinical outcomes of supracricoid laryngectomy with cricohyoidoepiglottopexy (SCL-CHEP) in irradiated and non-irradiated patients, we investigated the usefulness of salvage SCL-CHEP.
METHODS: 73 patients who received SCL-CHEP between 1997 and 2010 (30 had received radiation therapy preoperatively and 43 had not). Staging error, wound infection, accuracy of surgical margin determination, acquired laryngeal function, and prognosis were compared between the two groups.
RESULTS: Staging error occurred in 6/30 (20%) irradiated and 14/43 (33%) non-irradiated patients. An intraoperative margin study demonstrated a dysplastic or positive margin in 15/30 (50%) irradiated and 13/43 (30%) non-irradiated patients. Wound infection developed in 12/30 (40%) irradiated and 7/43 (16%) non-irradiated patients (P<0.05). Delayed wound infection was identified in four patients with a radiation dose over 65Gy. Swallowing function (ability to eat in public) was acquired in 28/30 (93%) irradiated and 39/43 (91%) non-irradiated patients. Five-year larynx preservation rates were 94% in irradiated and 91% in non-irradiated patients. Five-year overall survival rates were 81% in irradiated and 87% in non-irradiated patients.
CONCLUSIONS: Risk of infection was significantly higher in irradiated patients; delayed infection should be appropriately managed. Functional and oncological results were stable regardless of radiation history. We encourage head and neck surgeons to take reasonable risks in performing salvage SCL-CHEP.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22889564     DOI: 10.1016/j.anl.2012.07.014

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

Review 1.  Supracricoid partial laryngectomy for radiorecurrent laryngeal cancer: a systematic review of the literature and meta-analysis.

Authors:  Armando De Virgilio; Raul Pellini; Giuseppe Mercante; Giovanni Cristalli; Valentina Manciocco; Diana Giannarelli; Giuseppe Spriano
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-30       Impact factor: 2.503

2.  Attempt to improve functional outcomes in supracricoid laryngectomy in T2b and T3 glottic cancers.

Authors:  Małgorzata Leszczyńska; Małgorzata Wierzbicka; Maciej Tokarski; Witold Szyfter
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-21       Impact factor: 2.503

Review 3.  Supracricoid laryngectomy for recurrent laryngeal cancer after chemoradiotherapy: a systematic review and meta-analysis.

Authors:  C A Leone; P Capasso; D Topazio; G Russo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-12       Impact factor: 2.124

Review 4.  Oncological Outcomes of Primary vs. Salvage OPHL Type II: A Systematic Review.

Authors:  Carmelo Saraniti; Barbara Verro; Francesco Ciodaro; Francesco Galletti
Journal:  Int J Environ Res Public Health       Date:  2022-02-06       Impact factor: 3.390

5.  [Supracricoid partial laryngectomy (SCPL) with either cricohyoidoepiglottopexy (CHEP): our experience with 16 cases].

Authors:  Bouchaib Hemmaoui; Mohamed Sahli; Noureddine Errami; Ahmed Rouihi; Mohamed Habib Bahalou; Ilias Benchaifai; Amine Ennouali; Sara Britel; Ismail Nakkabi; Ali Jahidi; Mohamed Zalagh; Saloua Ouaraini; Fouad Benariba
Journal:  Pan Afr Med J       Date:  2017-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.